XML 72 R74.htm IDEA: XBRL DOCUMENT v3.20.1
Subsequent Events - Additional Information (Details) - Subsequent Event
$ in Millions
Feb. 28, 2020
USD ($)
Medexus Pharmaceuticals  
Subsequent Event [Line Items]  
Escrow amount $ 0.9
MidCap Financial  
Subsequent Event [Line Items]  
Repayment of full term debt facility 22.1
Principal payment of full term debt facility 20.0
Facility fee 2.1
Aptevo BioTherapeutics LLC | Medexus Pharmaceuticals  
Subsequent Event [Line Items]  
Cash received from sale of interest $ 30.0